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Abstract
Protein phosphatase 1 isoforms α, β, and γ (PP1α, PP1β, and PP1γ) are highly homologous in the
catalytic domains but have distinct subcellular localizations. In this study, we utilized both primary
cell culture and knockout mice to investigate the isoform-speciﬁc roles of PP1s in the heart. In
both neonatal and adult cardiac myocytes, PP1β was mainly localized in the nucleus, compared to
the predominant presence of PP1α and PP1γ in the cytoplasm. Adenovirus-mediated overexpression of PP1α led to decreased phosphorylation of phospholamban, which was not inﬂuenced by
overexpression of either PP1β or PP1γ. Interestingly, only cardiac-speciﬁc knockout of PP1β
resulted in increased HDAC7 phosphorylation, consistent with the predominant nuclear localization of PP1β. Functionally, deletion of either PP1 isoform resulted in reduced fractional shortening
in aging mice, however only PP1β deletion resulted in interstitial ﬁbrosis in mice as early as 3
weeks of age. Deletion of neither PP1 isoform had any effect on pathological cardiac hypertrophy
induced by 2 weeks of pressure overload stimulation. Together, our data suggest that PP1 isoforms have differential localizations to regulate the phosphorylation of their speciﬁc substrates for
the physiological function in the heart.
Key words: cardiac function, histone deacetylase, phospholamban, protein phosphatase 1

Introduction
The balance between protein phosphorylation and dephosphorylation regulates almost every aspect of biological processes [1]. In contrast to protein phosphorylation mediated by a vast number of
protein kinases, only a small number of protein phosphatases have
been reported [2]. Protein phosphatases are classiﬁed into three subgroups, namely serine/threonine, tyrosine, or dual speciﬁc phosphatases [3]. The serine/threonine protein phosphatases, which include
protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), and
protein phosphatase 2B (PP2B, also called calcineurin), account for
~98% of the phosphatase activities in the mammalian heart [4]. A
common feature for the serine/threonine phosphatases is that they
are holoenzymes composed of both catalytic subunits for the

enzymatic activity, and regulatory subunits that are either targeting
proteins or substrates [4]. The three catalytic subunits of PP1s
(PP1α, PP1β, and PP1γ), encoded by three distinct genes, are highly
homologous in their catalytic domains. Their divergent N- and
C-termini are hypothesized to underlie the target selectivity [5–7].
Sympathetic stimulation of cardiac myocytes generates cAMP
which in turn activates protein kinase A (PKA). PKA phosphorylates
many Ca2+ handling and myoﬁlament proteins involved in cardiac
contraction, such as ryanodine receptor 2 (RyR2), phospholamban
(PLB), troponin I (TnI), myosin light chain 2 V (MLC2V), and
myosin binding protein C [8–13]. Phosphorylation of sarcoplasmic
reticulum (SR) protein PLB at serine 16 by PKA or threonine 17 by
calcium-calmodulin-dependent protein kinases (CAMKs) increases
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Materials and Methods
Mice husbandry and transverse aortic constriction
surgery
All animal experimentation was approved by the Institutional
Animal Care and Use Committee at Grand Valley State University
(Protocol Number: 17-02-A). Mice used in this study were initially
generated in Dr. Molkentin’s laboratory at Cincinnati Children’s
Hospital (Cincinnati, USA) [17], and housed in standard rodent
cages, and observed daily for their wellbeing such as physical activity and food/water intake. To achieve cardiac-speciﬁc deletion of
PP1 isoforms, mice were targeted with Cre recombinase-dependent
LoxP sequences ﬂanking exon 3 of each PP1 gene as described previously [17]. These mice were subsequently crossed with NKX2.5-Cre
knock-in mice (030047; The Jackson Laboratory, Bar Harbor, USA)
to achieve PP1 deletion since early development [17]. Mice were
viable and had similar lifespan between all four groups (NKX-Cre,
PP1α ﬂ/ﬂNKX-Cre, PP1β ﬂ/ﬂNKX-Cre, and PP1γ ﬂ/ﬂNKX-Cre), except
PP1β deletion mice which developed cardiac dysfunction as early as
3 weeks of age. For mouse aging study, sex-matched mice were analyzed at 2, 4, and 8 months of age by echocardiography for the fractional shortening and other ventricular parameters.
The procedures for pressure overload by transverse aortic constriction (TAC) to induce cardiac hypertrophy have been previously

described [17]. In brief, 8-week-old sex-matched mice were anesthetized by 1.5% isoﬂurane to expose the transverse aortas through a
thoracotomy procedure. Constriction was performed with 7–0 silk
(Ethicon, Somerville, USA) around a ~27-gauge wire which was
slowly removed after the constriction. After the surgery, mice were
given pain medicine buprenex (0.1 mg/kg), and transferred to 30°C
chambers for overnight recovery before being transferred back to
the standard housing. After 2 weeks of TAC, Doppler echocardiography was ﬁrst applied to the mice to determine pressure gradients
across the constrictions to ensure similar stimulation for all the
mice. Cardiac function of the mice was analyzed by echocardiography using a SONOS 5500 instrument (Hewlett-Packard, Palo
Alto, USA) and a 15-MHz transducer. Left ventricular fractional
shortening percentage (FS) was calculated using left ventricle
internal diameters at the end of systole (LVIDs) and diastole
(LVIDd) based on the following formula: FS (%) = [(LVIDd
−LVIDs)/LVIDd] × 100%. At the end of the echocardiographic analysis, mice were euthanized by CO2 inhalation for 5 min followed by
cervical dislocation before the hearts were removed for the weight
measurement. Hearts were then ﬁxed overnight in 10% formalincontaining phosphate-buffered saline (PBS) and dehydrated for
embedding with parafﬁn. Serial 5-μm heart sections were stained
with Masson’s trichrome to detect interstitial ﬁbrosis shown as the
blue staining. Fibrosis was quantiﬁed as percentage of blue staining
of the tissue using ImageJ.

Isolation of cardiomyocytes and adenovirus infection
Neonatal rat hearts were digested with 0.01% trypsin (code TRLS;
Worthington, Lakewood, USA) in sterile calcium and magnesiumfree Hank’s Balanced Salt Solution (HBSS) for 16–20 h at 4°C with
gentle rotation. The next day, trypsin inhibitors (code SIC;
Worthington) were added to the digestion tube and incubated for
15 min at 37°C to stop the trypsin activity. Collagenases of 1500
units (code CLSPA; Worthington) were then added to the digestion
tube for an additional digestion for 60 min. Cells were collected
through a cell strainer, and plated into 0.01% gelatin-coated dishes
with 5% fetal bovine serum containing medium M199 (10-060-CV;
Corning, Corning, USA). After 60 min of culture, myocytes were
washed off the plates and seeded into new gelatin-coated dishes, while
the cells attached to the plates were considered as non-myocytes/
ﬁbroblasts. For adenovirus infection, neonatal myocytes were ﬁrst
switched to serum-free medium and then incubated with puriﬁed adenoviruses expressing either β-galactosidase [29] or PP1α (SL112646;
SignaGen Laboratories, Rockville, USA), PP1β (SL112778; SignaGen
Laboratories), PP1γ (SL112648; SignaGen Laboratories) for 2 h to
enhance infection efﬁciency. Later, 10% serum containing medium
was added to the myocytes for a total infection of 36 h. To analyze
the protein phosphorylation status inﬂuenced by PP1 expression,
myocytes were ﬁrst serum starved for 30 min in serum-free medium,
then stimulated with 10 μM isoproterenol (16504; Sigma, St Louis,
USA) for 5 min, and harvested into lysis buffer containing 20 mM
HEPES, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and protease/phosphatase inhibitors. Proteins were harvested after centrifugation, and after concentration quantiﬁcation, protein samples (10 μg)
were loaded for the western blot analysis. The primary antibodies
against the following proteins were used: pSer16-phospholamban
(A010-12AP; Badrilla, Leeds, UK), pThr17-phospholamban (A01013AP; Badrilla), phospholamban (MA3-922; Thermo Fisher, Waltham,
USA), and GAPDH (10–1500; Fitzgerald, Acton, USA).
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the ATPase activity of SR Ca2+ transport ATPase (SERCA) to
enhance Ca2+ reuptake into the SR [14]. In heart failure patients,
PP1 activities were found to be increased, suggesting that PP1s
might be the therapeutic targets for heart failure. Consistent with
this notion, adeno-associated virus (AAV) 9-mediated overexpression of phosphatase 1 inhibitor-1 (I-1) improved cardiac function,
while overexpression of a catalytic PP1α isoform in mice led to
reduced cardiac function and heart failure [15,16]. However,
cardiac-speciﬁc deletion of PP1β led to heart failure and cardiac
remodeling in mice [17]. These ﬁndings further extended the functional complexity of PP1 isoforms in the heart, possibly due to the
uncharacterized roles of PP1s in other subcellular locations such as
the nucleus [17–19].
Histone deacetylases (HDACs) are a group of enzymes that
remove the acetyl groups from lysine residues of a variety of target
proteins including histone and non-histone substrates [20,21]. In
mammalian cells, 18 HDACs have been identiﬁed and grouped into
ﬁve different subgroups I, IIa, IIb, III, and IV. In the heart, group IIa
HDACs (HDAC4, HDAC5, HDAC7, and HDAC9) have been
extensively studied and shown to be the endogenous inhibitors for
cardiac hypertrophy [20]. For example, overexpression of HDAC4,
HDAC5, and HDAC9 suppressed myocyte enhancer factor 2
mediated gene expression to prevent pathological stimuli-induced
cardiac hypertrophy [22–24]. Loss of either HDAC5 or HDAC9 led
to cardiac hypertrophy in mice [23,25]. Moreover, class II HDACs
are transcriptional repressors at resting state. Upon stimulation,
phosphorylation of class II HDACs led to their nuclear export,
resulting in the de-repression of their targeting genes [19,26–28].
However, the exact protein phosphatases that regulate the phosphorylation of HDACs have yet to be explored.
In the present study, we investigated the subcellular localization
of three PP1 isoforms and determined their speciﬁc substrates. In
addition, we determined whether PP1s play a role in physiological
and pathological heart function utilizing knockout mice with
cardiac-speciﬁc deletion of each isoform.

Isoform-speciﬁc roles of PP1 isoforms in the heart
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Isoform-speciﬁc roles of PP1 isoforms in the heart
Isolation of adult ventricular myocytes has been described previously [30]. Hearts were surgically removed from 2-month-old mice
after treatment with heparin (0.35 units) under anesthesia (Nembutal,
100 mg/kg), and cannulated for retrograde perfusion with a solution
containing liberase blendzyme (05401151001; Roche, Indianapolis,
USA). Heart tissues were dissociated by gentle pipetting and ﬁltered
into a new tube through a 500-μm mesh to eliminate the non-digested
tissues. Myocytes were allowed to settle by gravity followed by CaCl2
re-introduction. The cells in the pellet were considered as myocytes,
while those in the supernatant were considered as non-myocytes/ﬁbroblasts. Small aliquots of isolated cells were used to count rod-shaped
cardiac myocytes using a hemocytometer (02-671-6; Fisher Scientiﬁc,
Pittsburgh, USA). A high proportion (>80%) of rod-like cells were
used for the following RNA and immunoﬂuorescence analysis.

Immunocytochemistry

RNA isolation and real-time PCR
Total RNA was isolated from myocytes and ﬁbroblasts using the
RNeasy Fibrous Tissue Kit (74704; Qiagen, Hilden, Germany) and
quantiﬁed with a NANODROP 2000 Spectrophotometer (Thermo
Scientiﬁc). cDNA synthesis was performed using the SuperScript III
First-Strand Synthesis Kit (18080-051; Invitrogen, Carlsbad, USA)
on a regular PCR machine. Real-time PCR analysis was performed
using SYBR green dye (172–5274; Bio-Rad, Hercules, USA) on a
CFX96 real-time PCR detection system (Bio-Rad). The primers used
to determine the mRNA level of PP1s were as follows: PP1α, forward: 5′-cctccagagagcaactacctcttc-3′, reverse: 5′-acgtcttccacagtttgatg
ttgt-3′; PP1β, forward: 5′-aatatggaggttttccaccagaag-3′, reverse: 5′attgatgctagcacactcatggtt-3′; PP1γ, forward: 5′-tcttcctcagtcagcctatccttt3′, reverse: 5′-ctccggatacttgattttgtaggc-3′; and ribosomal protein 27 as
the internal control, forward: 5′-ggacgctactccggacgcaaag-3′, reverse: 5′cttcttgcccatggcagctgtcac-3′.

Nuclear fractionation and western blot analysis
Procedures for nuclear fractionation of proteins from a cell culture
have been previously described [30]. In brief, neonatal or adult rat
cardiac myocytes were collected into hypotonic buffer A (10 mM
HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.4% IGEPAL, and
protease inhibitors), and were then lysed on ice for 30 min. After centrifugation for 5 min at 15,000 g, the supernatant was collected as
cytosolic fraction and the pellet was further re-suspended into buffer
B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 10% glycerol,
and protease inhibitors). After 2 h of incubation on ice, proteins
eluted from the pellet were collected by centrifugation and considered
as nuclear proteins. After protein concentration quantiﬁcation, 40 μg
of cytosolic and nuclear proteins were loaded and separated by 10%
SDS-PAGE, transferred onto PVDF membrane, blocked with 5%
non-fat milk, and incubated with the following primary antibodies:
anti-PP1α antibody (sc-6104; Santa Cruz Biotechnology, Dallas,
USA), anti-PP1β antibody (07-1217; Millipore, Burlington, USA),
anti-PP1γ antibody (sc-6108; Santa Cruz Biotechnology), anti-GAPDH
antibody (10-1500; Fitzgerald), anti-Lamin A/C antibody (2032; Cell
Signaling Technology, Danvers, USA). Goat-anti-rabbit secondary antibody (P/N 925-32211; Li-COR, Lincoln, USA) and goat-anti-mouse
secondary antibody (P/N 925-32210; Li-COR) were utilized to visualize the results by the Licor-Odyssey system. Additional primary antibodies against HDAC7 (sc-74563; Santa Cruz Biotechnology) and
phospho-HDAC7 (3424; Cell Signaling Technology) were used for
the western blot analysis on heart tissues. Phosphorylation of MLC2
was detected by a ProQ-Diamond staining method as previously
described [17].

Statistical analysis
All the results were presented as the mean ± SEM. Statistical analysis
was performed using Microsoft Excel using Student’s t-test for two
group analysis or ANOVA followed by a Bonferroni post hoc test
for comparison of differences across multiple groups. P < 0.05 was
considered statistically signiﬁcant.

Results
Distinct subcellular localizations of PP1 isoforms
PP1 catalytic isoforms have been demonstrated to differentially
regulate the phosphorylation of myoﬁlament proteins including
myosin light chain 2 (MLC2) and myosin binding protein C [17].
However, little is known whether they are targeted to other subcellular locations to potentially regulate cardiac function. To address
this question, we compared the localizations of endogenous PP1s in
both neonatal and adult cardiac myocytes using isoform-speciﬁc
antibodies we previously identiﬁed [17]. The majorities of the PP1α
and PP1γ proteins in neonatal cells were in the cytoplasm compared
to their nuclear localization (100% versus 67%) (Fig. 1A,C). PP1β
was predominantly present in the nucleus (2.7 times more) (Fig. 1A,C).
We also assessed their localization in isolated adult rat cardiac myocytes which were fully differentiated. Compared to the absence of
PP1α and PP1γ in the nucleus, PP1β was also found in the nucleus
although not as obvious as in the neonatal cardiomyocytes (Fig. 1B).
To further biochemically conﬁrm this data, we performed a crude
nuclear fractionation experiment to study the relative distribution of
each PP1 isoform. In both neonatal and adult cells, PP1β was predominantly present in the nucleus compared to PP1α and PP1γ that had a
higher expression in the cytoplasm (Fig. 1D–F). These data showed
that PP1s have different localization, which indicates that PP1s might
regulate distinct targets due to their speciﬁc localization.

PP1α and PP1β differently regulate substrate
phosphorylation in the heart
Based on the subcellular localization of PP1 isoforms (Fig. 1), we
further investigated whether they preferentially dephosphorylate
substrates. Previous studies using either RNAi or knockout mice
have indicated PLB and MLC2V as the potential substrates [17,18].
Here, we used a gain-of-function approach to assess the phosphorylation of these targets by adenovirus-mediated overexpression of
each PP1 isoform in neonatal cardiac myocytes. Due to the low yield
and survival during culture, adult myocytes were not chosen for the
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Rat cardiac myocytes grown on laminin or gelatin-coated slides
were ﬁxed with 4% paraformaldehyde for 20 min followed by rinses
with PBS for three times. Cells were permeabilized with 0.3%
Triton X-100 for 15 min, then blocked with 3% bovine serum albumin for 20 min. Isoform-speciﬁc anti-PP1 antibodies or together
with anti-sarcomeric alpha-actinin antibody (A7732; Sigma, St
Louis, USA) were used for overnight staining, which were then
detected by Alexa Fluor 488 or Alexa Fluor 594 conjugated secondary antibody (A11032 and A11034; Thermo Fisher). DAPI (D1306;
Thermo Fisher) was used for counterstaining of the nucleus, and all
the images were taken using Nikon A1 confocal microscope (Tokyo,
Japan). Quantiﬁcation of the relative ﬂuorescence intensity of PP1
staining in the neonatal cardiac myocytes was performed by FIJIImageJ.
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Figure 1. Distinct subcellular localizations of PP1 isoforms in cardiac myocytes (A) Immunocytochemistry analysis of endogenous PP1 isoforms in neonatal
rat cardiac myocytes. Scale bar, 10 μm. (B) Immunocytochemistry analysis of endogenous PP1 isoforms in adult rat cardiac myocytes. Magniﬁcation, 400×.
(C) Quantiﬁcation of relative ﬂuorescence intensity of PP1 isoforms based on A using FIJI-ImageJ. *P < 0.05 vs cyto. Western blot analysis of PP1s in the cytoplasm (cyto) and nucleus (nucl) of neonatal (D) and adult (E) rat cardiac myocytes. Lamin A/C and GAPDH were used as controls for nuclear and cytosolic proteins respectively. (F) Quantiﬁcation of PP1 isoforms based on E. *P < 0.05 vs cyto. All the experiments were repeated three times with similar results.

biochemistry analysis. Overexpression of PP1α signiﬁcantly reduced
the phosphorylation of PLB in cells challenged with isoproterenol
(Fig. 2A–C). However, overexpression of either PP1β or PP1γ did
not alter the phosphorylation of PLB (Fig. 2D–I). These data suggest
that PP1α but not PP1γ, the PP1 isoform localized in the cytoplasm,
regulates the phosphorylation of PLB in the cytoplasm. Only expression of PP1β reduced the phosphorylation of MLC2, consistent with
the increased MLC2 phosphorylation upon knockout of PP1β from
the mouse heart (Fig. 2D) [17]. Because PP1β was also enriched in
the nucleus (Fig. 1), we sought to identify the nuclear substrate for
PP1β. As PP1β is involved in HDAC7 dephosphorylation in thymocytes [19], we ﬁrst assessed HDAC7 using cardiac-speciﬁc PP1 deletion mice (PP1α ﬂ/ﬂNKX-Cre, PP1β ﬂ/ﬂNKX-Cre, and PP1γ ﬂ/ﬂNKX-Cre
respectively) [17]. Compared to the NKX-Cre mice, deletion of
endogenous PP1β, but not PP1α or PP1γ, signiﬁcantly enhanced the
phosphorylation of HDAC7 (Fig. 3). Consistent with our previous
study, the phosphorylation of the myoﬁlament protein MLC2 was
increased in PP1β deletion hearts (Fig. 3B). Together, these data
showed that PP1s regulate different substrates, indicating they might
have different functional roles in the heart.

PP1s are essential for physiological cardiac function
Deletion of neither PP1 isoform from mouse heart led to any birth
defect, suggesting PP1s are not involved in cardiac development
[17]. To study whether PP1s have distinct functional roles in postnatal and adult hearts, we ﬁrst compared the PP1 levels between
neonatal and adult cells (Fig. 4A–C). The expression of PP1β was

increased signiﬁcantly in adult hearts, whereas PP1α and PP1γ maintained similar levels (Fig. 4B,C). Similarly from a real-time PCR analysis, PP1β expression was increased and signiﬁcantly higher than
PP1α and PP1γ in both cell types (myocytes and ﬁbroblasts) of adult
hearts (Fig. 4A). These data led us to hypothesize that PP1β plays an
essential role in the mouse heart. Indeed as early as 3 weeks of age,
PP1β ﬂ/ﬂNKX-Cre mice demonstrated increased interstitial ﬁbrosis
compared to other groups (Fig. 4F). Upon aging of these mice, deletion of either PP1 isoform led to reduced fractional shortening and
left ventricular end-diastolic diameter (LVIDd) (Fig. 4D,E). These
data suggest that PP1s are required for the normal cardiac function
although the exact target of PP1β is yet to be identiﬁed.
PP1s have been proposed as the therapeutic targets for heart disease
treatment. It is still unknown whether PP1s are involved in pathological
cardiac remodeling. To address this question, we subjected 8-week-old
NKX-Cre control mice or mice with cardiac-speciﬁc deletion of each
PP1 isoform to either a sham procedure or pressure overload stimulation
by TAC. Cardiac function analysis by echocardiography demonstrated
that after 2 weeks of TAC, fractional shortening was not signiﬁcantly
different among all groups of mice (Fig. 5A). Ventricular chamber dimensions (LVIDd and LVIDs) and septal width (LVSD) were all signiﬁcantly
increased after TAC except for PP1β ﬂ/ﬂNKX-Cre mice (Fig. 5B–D). It
is possible that TAC stimulation did not lead to further ventricular dilation or growth because PP1β ﬂ/ﬂNKX-Cre mice already had disease at baseline (Fig. 4F). Similar cardiac hypertrophic growth after TAC was
achieved among all groups (Fig. 5E). Moreover, histological analysis by
Masson’s trichrome staining also demonstrated that deletion of individual
PP1 isoform led to similar interstitial ﬁbrosis (blue staining) after TAC
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compared to the NKX-Cre mice (Fig. 5F,G). These data suggest that
PP1s are not involved in stress responses in the heart.

Discussion
Our study further extends the complex function of PP1s in the heart
due to their distinct subcellular localizations. Our major ﬁndings are

following. (1) PP1β mainly localizes in the nucleus to regulate the
phosphorylation of HDAC7 in addition to myoﬁlament protein
MLC2 [17]. Deletion of PP1β leads to cardiac dysfunction in mice,
possibly due to the combined roles of PP1β in both the cytoplasm
and nucleus. (2) Overexpression of PP1α reduces PLB phosphorylation, and deletion of PP1α results in reduced cardiac function in
aging mice. (3) PP1γ is not linked to any substrate in this study,
however its deletion also results in reduced cardiac function
(Fig. 4D,E).
PP1s are serine/threonine protein phosphatases that dephosphorylate a variety of cellular substrates. Our study here showed that
PP1α was localized in the cytoplasm to regulate the PLB phosphorylation, consistent with a previous study of PP1α in the heart using
transgenic mouse approach [16]. However, deletion of endogenous
PP1α from mouse heart did not alter PLB phosphorylation [17],
indicating that PP1α might have a dose-effect on PLB phosphorylation. In this study, we further demonstrated that PP1β had no effect
on PLB phosphorylation (Fig. 2D–F). Instead, PP1β was localized to
the nucleus to bind and regulate HDAC7 phosphorylation [19]
(Fig. 3). Although closely related to HDAC7, dephosphorylation of
HDAC4 is inﬂuenced by PP2A [31,32]. HDAC5 phosphorylation is
also inﬂuenced by PP2A [33]. However, our study didn’t provide
further mechanism on how PP1β regulates HDAC7 transcriptional
activity to control cardiac function. It is possible that dephosphorylation of HDAC7 by PP1β promotes its nuclear localization to suppress target gene expression as shown in thymocytes [19].
Congenital heart disease is one of the most common development disorders that affects ~8:1000 live births worldwide [34,35].
Missense variants in PPP1Cb gene were also implicated in congenital heart disease [36]. Although without any developmental defects
upon deletion of PP1β from embryonic stage using NKX2.5-Cre,
PP1β ﬂ/ﬂNKX-Cre mouse hearts demonstrated extensive interstitial
ﬁbrosis as early as 3 weeks of age and eventual reduction of cardiac
function (Fig. 4D,E). Further investigations are needed to determine
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whether this phenotype is due to transcriptional activity of HDAC7
or combined effect of phosphorylation of MLC2 (Fig. 2).
Interestingly, PP1α ﬂ/ﬂNKX-Cre and PP1γ ﬂ/ﬂNKX-Cre mice also
demonstrated eventual reduction of cardiac function, which was
possibly due to the compensational increase of other PP1s in these
hearts [17].
Upon 2 weeks of pathological stimulation by TAC, mice with
loss of either PP1 isoform developed similar hypertrophy and dysfunction compared to the controls, suggesting that PP1s are not
involved in this process (Fig. 5). It will be interesting to extend the
TAC stimulation to a longer period such as 14 weeks to assess
whether PP1s are involved in the decompensation of the heart to
failure. It is also possible that deletion of one isoform is compensated by increased levels of the other two isoforms, so the overall
PP1 activity is not inﬂuenced [17]. However, even deletion of PP1β
led to upregulation of both PP1α and PP1γ [17], PP1β ﬂ/ﬂNKX-Cre
still developed reduction of cardiac function (Fig. 4D–F), suggesting
that each PP1 isoform plays a unique role possibly due to their distinct subcellular localizations, which cannot be compensated by
other PP1 isoforms.
In summary, our study provides further insights into the physiological role of cardiac PP1s which regulate different cellular substrates. One future direction is to identify the target genes regulated
by PP1β to elucidate the pathology of PP1β ﬂ/ﬂNKX-Cre at 3 weeks of
age. PP1γ apparently does not regulate PLB or HDAC7 phosphorylation, but deletion of it also inﬂuences the physiological cardiac
function, suggesting that other potential substrates need to be veriﬁed or identiﬁed using our knockout models.
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